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This study aimed to discover candidate single nucleotide polymorphisms (SNPs) for hypothesizing significant biological
pathways of gastric cancer (GC). We performed an Identify Candidate Causal SNPs and Pathways (ICSNPathway) analysis
using a GC genome-wide association study (GWAS) dataset, including 472,342 SNPs in 2,240 GC cases and 3,302
controls of Asian ethnicity. By integrating linkage disequilibrium analysis, functional SNP annotation, and pathway-based
analysis, seven candidate SNPs, four genes and 12 pathways were selected. The ICSNPathway analysis produced 4
hypothetical mechanisms of GC: (1) rs4745 and rs12904→ EFNA1→ ephrin receptor binding; (2) rs1801019→
UMPS→ drug and pyrimidine metabolism; (3) rs364897→ GBA→ cyanoamino acid metabolism; and (4) rs11187870,
rs2274223, and rs3765524→ PLCE1→ lipid biosynthetic process, regulation of cell growth, and cation homeostasis. This
pathway analysis using GWAS dataset suggests that the 4 hypothetical biological mechanisms might contribute to GC
susceptibility.
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Despite a decline in its incidence, gastric cancer (GC) is
still the second most common cause of cancer-related
death worldwide (Hohenberger and Gretschel 2003).
Furthermore, GC remains one of the most prevalent
high-mortality cancers in Northeast Asia (Hohenberger
and Gretschel 2003). Helicobacter pylori infection is the
strongest risk factor for GC (Polk and Peek 2010), but
only a small proportion of infected individuals develop
malignancy. Thus, genetic factors such as polymorphisms
in GC-related genes, in addition to dietary factors and
environmental factors, substantially contribute to GC
susceptibility (Milne et al. 2009).
Genome-wide association studies (GWAS) have proved
successful in identifying associations between specific
genes and complex diseases (Manolio 2010), and opened a
new phase in researching the genetic causes of disease.
Furthermore, GWAS datasets are increasingly being used* Correspondence: apysk@korea.ac.kr
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in any medium, provided the original work is pto recognize the biological pathways underlying complex
diseases (Ramanan et al. 2012), because the functional
pathway analysis using genomic datasets has high statis-
tical power to detect the biological mechanisms of disease
causation (Ramanan et al. 2012).
Recently, (Zhang et al. 2011a) developed the pathway
analysis tool called Identify Candidate Causal SNPs and
Pathways (ICSNPathway) analysis. This method high-
lights the candidate SNPs and their corresponding can-
didate pathways from GWAS data by integrating linkage
disequilibrium (LD) analysis, functional SNP annotation,
and pathway-based analysis (PBA) (Zhang et al. 2011a).
The ICSNPathway analysis provides candidate SNPs and
their corresponding candidate pathways using GWAS
data, thereby making it easier to link variants to bio-
logical mechanisms.
We conducted ICSNPathway analysis using a GC
GWAS dataset available online to identify candidate
SNPs and promising biological mechanisms that contribute
to GC susceptibility.pen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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GWAS dataset
The GC GWAS dataset is publicly available from the
NCBI dbGap (http://www.ncbi.nlm.nih.gov/gap). The
dataset includes genotypes of 472,342 SNPs on Illumina
660 W Quad chip from 2,240 GC cases and 3,302 con-
trols of Chinese ethnicity (Abnet et al. 2010; Li et al.
2013). Study participants were drawn from the Shanxi
Upper Gastrointestinal Cancer Genetics Project and the
Linxian Nutrition Intervention Trial, which included a
total of 1,625 GC cases and 2,100 controls. Six hundred
and fifteen GC cases and 1,202 controls from the Shanghai
Men’s Health Study, the Shanghai Women’s Health Study,
and the Singapore Chinese Health Study were also in-
cluded in the database. Controls were matched for age
(±5 years), sex, and geographical location and they were
all cancer-free at the time of enrollment (Abnet et al.
2010; Li et al. 2013). The dataset was filtered to prevent
genotyping errors. The SNPs were excluded if they
showed a call rate lower than 90% in cases or controls or
significant deviation from Hardy-Weinberg equilibrium in
the controls (P < 10–4). Finally, 470,698 SNPs were left for
downstream pathway analysis.
ICSNPathway analysis
We conducted ICSNPathway analysis using the GC
GWAS dataset in two-stages (Zhang et al. 2011a). First,
candidate causal SNPs were pre-selected by LD analysis
and the most significant functional SNPs were anno-
tated. Next, biological mechanisms for the pre-selected
candidate causal SNPs were found using PBA. A full list
of GWAS SNP P-values was used for the ICSNPathway
analysis. The ICSNPathway analysis is based on LD analysis
and the discovery of functional SNPs using improved-gene
set enrichment analysis (i-GSEA). The ICSNPathway
searches for SNPs in LD with the most significant SNPs in
a GWAS dataset to identify more possible candidate causal
SNPs based on the extended dataset, such as HapMap data.
We selected the optional parameters for LD: Chinese Han
in Beijing as the HapMap population; a cut-off for LD
measurement of r2 = 0.8; and a maximum distance to
search LD neighborhoods of 200 kb. The ICSNPathway
pre-selects candidate causal SNPs based on functional
SNPs, which are defined as SNPs that may alter protein,
gene expression or the role of protein in the context of the
pathway. Functional SNPs include deleterious and non-
deleterious, non-synonymous SNPs; SNPs leading to the
loss or gain of a stop codon; SNPs resulting in a frame shift;
SNPs located at essential splice sites; and SNPs in regula-
tory regions. The ICSNPathway server detects pathway-
associated traits in the full list of GWAS SNP P-values
using i-GSEA.
The term “most significant SNPs” denotes SNPs with a
P-value below a certain threshold. The P-value thresholdto extract the most significant SNPs can be specified
using the GWAS SNP P-values. The ICSNPathway analysis
presents the most significant pathways from the original
GWAS when a P-value threshold less than 1 × 10−4 is
chosen. Two parameters were set for the analysis. The first
parameter was ‘within gene only’ meaning that only the P-
values of SNPs located within genes were utilized in the
PBA algorithm. The second was a false discovery rate
(FDR) cut-off of 0.05 for multiple testing corrections. The
FDR, which is defined as the expected proportion of false
positives among all significant tests, allows researchers to
identify a set of positive candidates. We used cut-offs of 5
minimum and 100 maximum in order to avoid overly
narrow or overly broad functional categories.
The ICSNPathway analysis used four pathway databases
including the Kyoto Encyclopedia of Genes and Genomes
(http://www.genome.jp/kegg/pathway.html) (Kanehisa et al.
2010), BioCarta (http://www.biocarta.com/genes/index.asp),
Gene Ontology biological process (http://www.geneon
tology.org) (Ashburner et al. 2000), and Gene Ontology
molecular function (http://www.broadinstitute.org/gsea/
msigdb/index.jsp). When a candidate SNP was not present
on a particular genotyping array, proxy SNPs in LD for
that candidate SNP were identified, based on observed
LD patterns in HapMap. Therefore, SNP annotation
and proxy search (SNAP) was performed, which is a
tool for the identification and annotation of proxy
SNPs using HapMap.
Results
Using GWAS SNP P-values as inputs, the ICSNPathway
analysis identified seven candidate causal SNPs, four
genes, and 12 candidate causal pathways (http://ICSN
Pathway.psych.ac.cn/getResult.do?tag=4904B29B74A5130
7E8CFD85B4466A802_1374721534621) (Tables 1 and 2)
(Figure 1). SNPs rs4745 and rs12904, which were not rep-
resented in the original GWAS, are in LD with rs4460629
(r2 = 1.0) (-log10 (P) = 6.472). SNPs rs1801019, rs364897
and rs11187870, which were not represented in the ori-
ginal GWAS, were in LD with rs4234221, rs4460629 and
rs3781264, respectively (r2 = 0.824, 0.924, 0.857) (-log10
(P) = 4.087, 6.472, 10.405, respectively). SNPs rs2274223
and rs3765524, which were represented in the original
GWAS (-log10 (P) = 8.633 and 8.556, respectively), were
not in LD with any SNP.
The seven candidate causal SNPs and 12 candidate
causal pathways provided four hypothetical biological
mechanisms for GC: (1) rs4745 (non-synonymous coding)
and rs12904 (regulatory region) to EFNA1 gene to ephrin
receptor binding; (2) rs1801019 (non-synonymous coding)
to Uridine Monophosphate Synthetase (UMPS) gene to
drug and pyrimidine metabolism; (3) rs364897 (non-syn-
onymous coding) to Glucocerebrosidase (GBA) gene to
cyanoamino acid and starch/sucrose metabolism; and (4)
Table 1 Candidate causal SNPs and pathways
Candidate SNP Functional class Gene Candidate causal pathway* -log10(P)† In LD with r
2 D’ -log10(P)‡
rs4745 Nonsynonymous coding EFNA1 1 - rs4460629 1.0 1.0 6.472
rs12904 Regulatory region EFNA1 1 - rs4460629 1.0 1.0 6.472
rs1801019 Nonsynonymous coding UMPS 2,3 - rs4234221 0.824 1.0 4.087
rs364897 Nonsynonymous coding GBA 4,11 - rs4460629 0.924 1.0 6.472
rs11187870 Regulatory region PLCE1 5,6,7,8,9,10,12 - rs3781264 0.857 1.0 10.405
rs2274223 Nonsynonymous coding PLCE1 5,6,7,8,9,10,12 8.633 rs2274223 - - 8.633
rs3765524 Nonsynonymous coding PLCE1 5,6,7,8,9,10,12 8.556 rs3765524 - - 8.556
SNP; single nucleotide polymorphism, LD; linkage disequilibrium.
*numbers indicate the indexes of pathway ranked significance (false discovery rate).
†-log10 (P) values of candidate causal SNPs in the original genome wide association studies (GWAS), - denotes that this SNP is not represented in the
original GWAS.
‡-log10 (P) values of SNPs in LD with candidate causal SNPs in the original GWAS.
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ous coding) and rs3765524 (non-synonymous coding) to
Phospholipase C epsilon 1 (PLCE1) gene to growth, kidney
development, cellular cation homeostasis, urogenital sys-
tem development, lipid biosynthetic process, regulation of
cell growth, and cation homeostasis (Tables 1 and 2).
Discussion
The results of previous GWAS studies have suggested that
the rs227423 at 10q23 (Abnet et al. 2010), rs1336107 at
5q13, rs9841504 at 3q13 (Shi et al. 2011), and rs2976392
and rs2294008 at 8q24 (Sakamoto et al. 2008) SNPs are
associated with GC. Although individual GWAS has been
successful in finding new susceptibility genes for various
complex diseases, none of the GWAS datasets was ana-
lyzed to their full potential (Elbers et al. 2009). Individual
GWAS data has focused on SNPs with high statistical sig-
nificance, whereas the other many SNPs have receivedTable 2 Candidate causal pathways
Index Candidate causal pathway Description
1 Ephrin receptor binding Interacting selectively and n
2 Hsa00983 Drug metabolism – other e
3 Hsa00240 Pyrimidine metabolism
4 Hsa00460 Cyanoamino acid metabolis
5 Growth The increase in size or mass
an organism or a cell
6 Kidney development The process whose specific
kidney over time, from its fo
7 Cellular cation homeostasis The regulation of the levels
within a cell or between a
8 Urogenital system development The process whose specific
system over time, from its f
9 Lipid biosynthetic process The chemical reactions and
10 Regulation of cell growth Any process that modulate
11 Hsa00500 Starch and sucrose metabo
12 Cation homeostasis The regulation of the levels
FDR; false discovery rate.little attention. Thus, pathway analysis of genomic data
with gene set enrichment approach could highlight sig-
nificant SNPs that have otherwise been hidden during
gene- or SNP- based analysis (Ramanan et al. 2012;
Elbers et al. 2009).
In this study, we identified seven candidate causal
SNPs, four genes, and 12 candidate pathways by ICSN-
Pathway analysis. The candidate SNPs and pathways
provided four hypothetical biological mechanisms. In this
genome-wide pathway analysis, the most significant GC-
associated pathway was that of ephrin receptor binding.
The EFNA1 (ephrinA1), located within chromosomal
region 1q21-q22, is a glycosylphosphatidylinositol (GPI)
linkage ligand with a 205-amino acid chain that prefer-
entially binds to the receptor tyrosine kinase EphA2 at
sites, where cell-cell contact occurs (Wykosky and
Debinski 2008). Some studies have shown an association
between GC and EFNA1. (Li et al. 2012) reported thatNominal P FDR
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Figure 1 Regional LD plots of rs4745 (EFNA1) (a), rs12904 (EFNA1) (b), rs1801019 (UMPS) (c), and rs11187870 (PLCE1) (d) SNPs. SNPs are plotted
along with proxies (based on HapMap data on Chinese Han in Beijing) as a function of genomic location and are annotated by recombination
rate across the locus (light-blue line). On the y-axis, pairwise r2 values are provided for each proxy SNP using color codes.
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ciated with GC risk. (Nakamura et al. 2005) also
reported that EFNA1 was overexpressed in 57% of GC
tissue samples. Our pathway analysis suggests that the
EFNA1 gene and ephrin receptor binding pathway may
play an important role in GC susceptibility.
The UMPS is a fundamental enzyme in pyrimidine
synthesis (Gusella et al. 2011). A small-scale study in 23
GC patients indicated that UMPS polymorphisms are
not related to cancer risk in Caucasian GC patients
(Gusella et al. 2011). However, further studies are needed
to clarify the effects of the candidate UMPS gene and
UMPS-associated pathways on the development of GC.
The GBA, located in 1q21-22, encodes a glucocerebrosi-
dase, which catalyzes the hydrolysis of glucocerebroside, a
membrane glycolipid, to ceramide and glucose (Velayati
et al. 2010). The association of GBA gene mutation with
Gaucher’s disease, Parkinson disease, or Lewy body dis-
order has been reported (Velayati et al. 2010). However, to
the best our knowledge, candidate GBA and its pathways
have not been investigated in GC.
The PLCE1 gene on chromosome 10q23 encodes an en-
zyme that catalyzes the hydrolysis of phosphatidylinositol-
4,5-biphosphate, generating the secondary messengers
inositol 1,4,5-triphosphate and diacylglycerol, which
participate in cell growth and differentiation (Bunney
et al. 2009). Several studies have reported that the
rs2274223 polymorphism in PLCE1 is a risk factor forGC in the Chinese Han population (Abnet et al. 2010;
Zhang et al. 2011b; Wang et al. 2012). In addition, (Luo
et al. 2011) suggested that GC patients with this SNP
have a survival advantage. However, no significant asso-
ciation was observed between rs2274223 polymorphism
and GC in a Caucasian population (Palmer et al. 2012;
Kupcinskas et al. 2014).
Previous studies of GC GWAS have suggested that
prostate stem cell antigen (PSCA) and MUC1 SNPs are
associated with GC risk (Kupcinskas et al. 2014; Rizzato
et al. 2013). However, the pathway analysis in our study
could not identify these SNPs. This discordance may be
caused by several factors, such as ethnic diversity, differ-
ences in sample size or type, and variable GWAS array
chips.
Several web servers for pathway analysis of GWAS
have been offered: i-GSEA4GWAS (http://gsea4gwas.psy
ch.ac.cn), VEGAS (https://vegas2.qimrberghofer.edu.au)
and DAVID (http://david.abcc.ncifcrf.gov). We selected
the ICSNPathway because it is an updated version of
i-GSEA4GWAS and has advantages in exploring candi-
date causal SNPs, genes, and disease associations (Zhang
et al. 2011a).
The present ICSNPathway analysis has some limitations.
First, incomplete annotation of the human genome is an
important shortcoming of the pathway-based approach. In
addition, imperfect knowledge of their genetic basis in
complex diseases may decrease the ability of ICSNPathway
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quent replication studies are required to confirm the candi-
date SNPs, genes, and associated pathways (Jia et al. 2011).
However, replication in independent datasets is beyond the
scope of this study. Pathway analyses using GWAS datasets
can be a useful tool in discovering novel genes that are
associated with disease susceptibility (Ramanan et al. 2012;
Zhang et al. 2011a).
It is rather arbitrary to determine the appropriate
threshold for significant SNPs (Ramanan et al. 2012;
Lambert et al. 2010). The cut-off levels for significant
SNPs have ranged from P < 0.05 to P < 5 × 10-8 (Ramanan
et al. 2012). (Lambert et al. 2010) reported that pathway
analyses were performed using different levels of cut-off
values (<0.01, <0.001, or <0.0001). However, there was little
difference in finding significant pathways according to
these cut-off values. We adopted P value of 1× 10-4, con-
sidering the number of significant SNPs which could be
entered for the pathway analysis.
In conclusion, we carried out ICSNPathway analysis
using the GC GWAS data to evaluate genetic associations
with GC at the SNP and pathway levels, considering that a
pathway-based approach improves the results of individual
SNP analyses of GWAS datasets. We identified seven
candidate causal SNPs and four genes, and developed
four hypotheses that possibly contribute to GC suscepti-
bility. Further studies are needed to confirm and explore
genetic variations of the hypothetical pathways underlying
GC susceptibility.
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